3.0
May 15, 2024
A lot of potential but could be better
Current employee, more than 1 year
Cambridge, East of England, England
Recommend
CEO approval
Business Outlook
Pros
Really smart people Great facilities Interesting science
Cons
Has been described as a passive-aggressive organisation which is very true - hard to get things done People generally unhappy and disengaged, due to low pay, high workloads and little transparency from upper management Not the most innovative of Big pharma - content to fast follow and acquire late stage assets once validated rather than invest in their own original R&D Hard to get promoted and unclear what is required to progress